Commentary
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
In 1984, the United States Congress passed the National Organ Transplant Act that called for a national network to coordinate the procurement and allocation of organs for transplantation and for the collection of clinical data related to
[read more...]Despite our current understanding regarding the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), only one therapy has been approved by the US FDA. There has been recent interest in redefining end points for clinical trials
[read more...]Congo red is synonymous with amyloidosis. The visually stunning apple green birefringence lights up the eyes and minds of pathologists and nephrologists. Like many histological stains, Congo red was originally a textile dye that was later used to
[read more...]Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, often results in the need for renal replacement therapy, and is the etiology for renal failure in 10% of dialysis patients. Few treatment options
[read more...]More than 26 million Americans are affected by chronic kidney disease (CKD), and the prevalence of CKD is increasing. In addition, there is growing evidence that minority populations are disproportionately affected by CKD. African Americans often
[read more...]World Kidney Day (WKD), established in 2006, is an initiative to raise awareness about the health burden of kidney disease. The theme for World Kidney Day 2019 is global awareness, with a focus on disparities and inequities due to social
[read more...]Editors’ Note: We are always happy to see the implementation of research published in AJKD. Please see below for a description of a bedside tool developed to help clinicians provide families of children with CKD with estimated progression
[read more...]In late 2009, the primary results of the placebo-controlled Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) were published. TREAT randomized 4,038 patients with anemia and type 2 diabetes with estimated GFR (eGFR) of 20 to 60
[read more...]Over the last few years, the management of hepatitis C has been revolutionized by the advent of direct antiviral agents (DAA). This has arguably been one of the most impactful advancements in medicine over the last decade, potentially affecting
[read more...]Discussion about renal replacement therapy selection in our patients with CKD is complex, but an important part of any nephrology practice. If we know the patient well, it can be straightforward, maybe even “predictable.” Even in those best-case
[read more...]
